{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-025654","form_type":"8-K/A","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.082713+00:00","generated_at":"2026-05-31T10:19:35.341533+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cassava Sciences corrects diluted EPS for H1 2024 to ($0.28) from ($1.72)","bullets":["Corrected diluted EPS for six months ended June 30, 2024 is $(0.28), not $(1.72) as originally reported.","No other financial figures in the August 8, 2024 earnings release are affected by this amendment.","Corrected figure matches diluted EPS reported in the Form 10-Q filed on August 8, 2024.","Amendment filed on August 9, 2024; initial 8-K remains unchanged except for the EPS correction."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-025654","json":"https://secwatch.observer/filing/0001437749-24-025654.json","markdown":"https://secwatch.observer/filing/0001437749-24-025654.md","text":"https://secwatch.observer/filing/0001437749-24-025654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/0001437749-24-025654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/sava20240809_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:19:35.341533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}